Abstract
Get full access to this article
View all access options for this article.
References
1.
Court of First Instance of the European Communities (Fifth Chamber, Extended Composition) of 26th October, 2000 in Case T-41/96 Bayer v Commission [2000] ECR II-3383 by which the Court annulled Commission Decision 96/478/EC of 10th January, 1996 relating to a proceeding under Article 85 of the EC Treaty (Case IV/34.279/F3 - ADALAT) (OJ 1996 L 201, p. 1; the contested decision).
2.
European Court of Justice of 6th January, 2004 (Appeals - Competition - Parallel imports - Article 85(1) of the EC Treaty (now Article 81(1) EC) - Meaning of agreement between undertakings - Proof of the existence of an agreement - Market in pharmaceutical products) in Joined Cases C-2/01 P and C-3/01 P.
3.
Case C-53/03 Synetairismos Farmakopoion Aitolias & Akarnanias (Syfait) and Others v GlaxoSmithKline AEVE (SYFAIT v GSK).
4.
COM (2003 ) 383/F of 01/07/2003 Department responsible: Enterprise communication from the commission to the council, the European parliament, the economic and social committee and the committee of the regions. A Stronger European-based Pharmaceutical Industry for the Benefit of the Patient — A Call for Action.